<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04343196</url>
  </required_header>
  <id_info>
    <org_study_id>Kinepict-008</org_study_id>
    <nct_id>NCT04343196</nct_id>
  </id_info>
  <brief_title>Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction</brief_title>
  <official_title>Application of Digital Variance Angiography in Diagnostic Lower Limb Angiographiy for Radiation Exposure Reduction a Prospective Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kinepict Health Ltd.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Semmelweis University Heart and Vascular Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kinepict Health Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Digital Variance Angiography (DVA) is a new tool in medical imaging with proven image quality
      reserve.

      The previously observed quality reserve of Digital Variance Angiography (DVA) in lower
      extremity angiographies, allowed to lower radiation exposure by 70 % during DSA in lower
      extremity diagnostic angiographies with non-inferior image quality.

      The aim of this study is to apply this non-inferior image quality and use it for radiation
      exposure reduction in diagnostic lower limb angiography.

      The project would prospectively block-randomize (50:50) patients, who undergo elective
      diagnostic angiography into two groups: a comparator group examined by means of conventional
      DSA using a standard care protocol (Siemens Artis Zee, Extremities Care setting, 1.2
      µGy/frame) (Group B) and a study group examined by means of DVA using a low-dose protocol
      (0.36 µGy/frame corresponding to 70% decrease of radiation dose) (Group A). During each
      procedure the investigators record radiation exposure (cumulative dosage, dose area product)
      and contrast media usage and procedural time then compare the results of the groups.

      Our hypothesis is that with the previously proven non-inferior image quality, the
      investigators will be able to reduce radiation exposure of the participants and also staff
      members in everyday clinical practice.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>All enrolled participants will undergo a diagnostic lower limb angiography, but the image acquisition protocol will be different. In the active comparator group a normal radiation dose will be used and the DSA images will be used for diagnosis whereas in the experimental group a low dose radiation will be applied (70% decrease compared tot he DSA protocol) and the DVA images will be used for diagnosis.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total procedural Dose-area product(DAP)</measure>
    <time_frame>During the procedure</time_frame>
    <description>Indicator of a patient's irradiation dosage (microGy*cm2 or Gy*cm2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total DSA-related DAP</measure>
    <time_frame>During the procedure</time_frame>
    <description>Radiation load of the patient during DSA image acquistion (microGy*cm2 or Gy*cm2)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Contrast media usage</measure>
    <time_frame>During the procedure</time_frame>
    <description>The volume of the iodinated contrast agent used for enhancing the image quality (mL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of protocol change</measure>
    <time_frame>During the procedure</time_frame>
    <description>The number of occasions when the reduced radiation level protocol has to be switched back to conventional protocol in one region because of unsuitable image quality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure time</measure>
    <time_frame>During the procedure</time_frame>
    <description>Duration of the whole procedure, from radial artery puncture till the removal of every tool (min).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Peripheral Artery Disease</condition>
  <condition>Femoral Artery Stenosis</condition>
  <condition>Femoral Artery Occlusion</condition>
  <condition>Popliteal Stenosis</condition>
  <condition>Iliac Artery Stenosis</condition>
  <condition>Crural Artery Thrombosis</condition>
  <condition>Limb Ischemia</condition>
  <arm_group>
    <arm_group_label>Group A: Low-dose DVA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Image acquisition at a reduced X-ray dose, 0.36 µGy/frame (70% reduction) image processing by DVA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: Normal-dose DSA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Image acquisition at a normal dose (1.2 µGy/frame) image processing by DSA</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Diagnostic Angiography (DSA or DVA based on randomization result)</intervention_name>
    <description>After radial/brachial/femoral artery puncture using Seldinger technique, the investigators first position a pigtail catheter above the level of the renal arteries. With Siemens Artis Zee Pure DSA machine the examiner will use a postero-anterior X-ray view for the first image, which is an aortography of some part of the iliac system. Then, the catheter will be repositioned to the aortic bifurcation and 15-18 mL contrast media (CM) with 9-10 mL/s flow for the ilio-femoral region will be injected. All of the following image series will be made from this catheter position, with a 9 mL/s flow rate. In cases for when the recorded image series will be inconclusive, image series with left/right oblique position will be recorded. All femoro-popliteal images will be recorded with 10-16 ml CM and crural regions with 12-22mml. DSA images will be calculated from all series on a dedicated Syngo workstation and used for diagnosis. DVA images will be calculated by the Kinepict Medical Imaging Tool</description>
    <arm_group_label>Group A: Low-dose DVA group</arm_group_label>
    <arm_group_label>Group B: Normal-dose DSA group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with lower limb peripheral arterial disease, admitted for diagnostic
             angiography

          -  Fontaine II- IV

          -  Normal renal function: GFR&gt; 60ml/min/m2

          -  Age &gt; 18

        Exclusion Criteria:

          -  Acute myocardial infarction

          -  Severe heart/liver/renal failure

          -  Iodine contrast allergy

          -  Atrioventricular block

          -  Coagulopathy and Hematological Bleeding Disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krisztián Szigeti, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Kinepict Health Ltd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Szabolcs Osváth, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Kinepict Health Ltd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>János Kiss, M.D.,Ph.D.,D.Sc.</last_name>
    <role>Study Chair</role>
    <affiliation>Kinepict Health Ltd.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Péter Sótonyi, Prof., M.D., Ph.D.</last_name>
    <phone>00-36-208258046</phone>
    <email>sotonyi@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Balázs Nemes, M.D., Ph.D.</last_name>
    <phone>00-36-208258041</phone>
    <email>ersebrtg@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Semmelweis University, Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Péter Sótonyi, Prof., M.D., Ph.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>Balázs Nemes, M.D., Ph.D.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Márton Berczeli, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcell Gyánó, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <link>
    <url>http://kinepict.com</url>
    <description>Homepage for the Kinepict scientific group, source for additional information about digital variance angiography</description>
  </link>
  <reference>
    <citation>Óriás VI, Gyánó M, Góg I, Szöllősi D, Veres DS, Nagy Z, Csobay-Novák C, Zoltán O, Kiss JP, Osváth S, Szigeti K, Zoltán R, Sótonyi P. Digital Variance Angiography as a Paradigm Shift in Carbon Dioxide Angiography. Invest Radiol. 2019 Jul;54(7):428-436. doi: 10.1097/RLI.0000000000000555.</citation>
    <PMID>30829769</PMID>
  </reference>
  <reference>
    <citation>Gyánó M, Góg I, Óriás VI, Ruzsa Z, Nemes B, Csobay-Novák C, Oláh Z, Nagy Z, Merkely B, Szigeti K, Osváth S, Sótonyi P. Kinetic Imaging in Lower Extremity Arteriography: Comparison to Digital Subtraction Angiography. Radiology. 2019 Jan;290(1):246-253. doi: 10.1148/radiol.2018172927. Epub 2018 Oct 16.</citation>
    <PMID>30325284</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2020</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Radiation protection</keyword>
  <keyword>X-ray angiography</keyword>
  <keyword>Digital Variance Angiography</keyword>
  <keyword>Digital Subtraction Angiography</keyword>
  <keyword>Peripheral Arterial Disease</keyword>
  <keyword>Kinepict</keyword>
  <keyword>Image acquistion</keyword>
  <keyword>Image quality</keyword>
  <keyword>Radiation exposure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

